Smolka, a biochemist and former interim director of the Weill Institute for Cell and Molecular Biology, will support life sciences across the university. His two-year appointment began May 1. Smolka succeeds Hector Aguilar-Carreño, professor ...
Read More
Three innovative approaches to treating infections, fighting cancer, and enhancing the body’s immune system have been selected for funding through the Cornell Center for Immunology’s 2025 Multidisciplinary Seed Grants. Read more here.
The new platform, which provided 100% protection from influenza and COVID-19 in mouse models, could vastly improve vaccine administration and the efficacy of the current flu vaccine. Read more here.
Krystyn J. Van Vliet has been named vice president for innovation and external engagement strategy, and Gary Koretzky ’78 will serve as interim vice provost for research. Read more here.
